Staphylococcal toxic shock syndrome toxin-1 inhibits monocyte apoptosis

Journal of Allergy and Clinical Immunology

Volumn 103, Issue 5 II, 1999, Pages 895-900

  Bratton, Donna L ^a,b   May, Kathleen R ^a   Kailey, Jenai M ^a   Doherty, Dennis E ^a,c   Leung, Donald Y M ^a,b  

^a NATIONAL JEWISH MEDICAL AND RESEARCH CENTER   (United States)

^b University of Colorado Denver and Children s Hospital Colorado   (United States)

^c UNIVERSITY OF KENTUCKY MEDICAL CENTER   (United States)

Author keywords

Apoptosis; Atopic dermatitis; Granulocyte macrophage colony stimulating factor; Monocyte; Staphylococcal exotoxins

Indexed keywords

EXOTOXIN; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; STAPHYLOCOCCUS TOXIN;

APOPTOSIS; ARTICLE; ATOPIC DERMATITIS; CELL CULTURE; CELL INTERACTION; CELL SURVIVAL; CYTOKINE PRODUCTION; DISEASE ASSOCIATION; HUMAN; HUMAN CELL; PRIORITY JOURNAL; STAPHYLOCOCCUS AUREUS; STAPHYLOCOCCUS INFECTION; TOXIC SHOCK SYNDROME;

APOPTOSIS; BACTERIAL TOXINS; DERMATITIS, ATOPIC; DOSE-RESPONSE RELATIONSHIP, DRUG; ENTEROTOXINS; GRANULOCYTE-MACROPHAGE COLONY-STIMULATING FACTOR; HUMANS; MONOCYTES; STAPHYLOCOCCUS AUREUS; SUPERANTIGENS;

EID: 0033033445     PISSN: 00916749     EISSN: None     Source Type: Journal    
DOI: 10.1016/s0091-6749(99)70435-5     Document Type: Article

References (25)

1. Leung DYM. Atopic dermatitis: the skin as a window into the pathogenesis of chronic allergic diseases. J Allergy Clin Immunol 1995;96:302-18.
2. Mihm MC, Soter NA, Dvorak HF, Austen KF. The structure of normal skin and the morphology of atopic eczema. J Invest Dermatol 1976;67:305-12.
3. Leung DYM, Bhan AK, Schneeberger EE, Geha RS. Characterization of the mononuclear cell infiltrate in atopic dermatitis using monoclonal antibodies. J Allergy Clin Immunol 1983;71:47-56.
4. Bratton DL, Hamid Q, Boguniewicz M, Doherty DE, Kailey JM, Leung DYM. Granulocyte macrophage-colony stimulating factor contributes to enhanced monocyte survival in chronic atopic dermatitis. J Clin Invest 1995;95:211-8.
5. Hamid Q, Boguniewicz M, Leung DYM. Differential in situ cytokine gene expression in acute vs. chronic atopic dermatitis. J Clin Invest 1994;94:870-6.
6. Ying S, Meng Q, Taborda-Barata L, Kay AB. Association of apoptosis of neutrophils and eosinophils and their ingestion by macrophages with resolution of the allergen-induced cutaneous late-phase response in atopic human subjects. Proc Assoc Am Physicians 1997;109:42-50.
7. Simon H-U, Yousefi S, Schranz C, Schapowal A, Bachert C, Blaser K. Direct demonstration of delayed eosinophil apoptosis as a mechanism causing tissue eosinophilia. J Immunol 1997;158:3902-8.
8. Wedi B, Raap U, Lewrick H, Kapp A. Delayed eosinophil programmed cell death in vitro: a common feature of inhalant allergy and extrinsic and intrinsic atopic dermatitis. J Allergy Clin Immunol 1997;100:536-43.
9. Leyden JJ, Marples RR, Kligman AM. Staphylococcus aureus in the lesions of atopic dermatitis. Br J Derm 1974;90:525-30.
10. Leung DYM, Harbeck R, Bina P, Hanifin JM, Reiser RF, Sampson HA. Presence of IgE antibodies to staphylococcal exotoxins on the skin of patients with atopic dermatitis: evidence for a new group of allergens. J Clin Invest 1993;92:1374-80.
11. Marrack P, Kappler J. The Staphylococcal enterotoxins and their relatives. Science 1990;248:705-11.
12. Mangan DF, Welch GR, Wahl SM. Lipopolysaccharide, tumor necrosis factor-α, and IL-1β prevent programmed cell death (apoptosis) in human peripheral blood monocytes. J Immunol 1991;146:1541-6.
13. Doherty DE, Haslett C, Tonnesen MG, Henson PM. Human monocyte adherence: a primary effect of chemotactic factors on the monocyte to stimulate adherence to human endothelium. J Immunol 1987;138:1762-71.
14. Chan SC, Li S-H, Hanifin JM. Increased interleukin-4 production by atopic mononuclear leukocytes correlates with increased cyclic adenosine monophosphate-phosphodiesterase activity and is reversible by phosphodiesterase inhibition. J Invest Dermatol 1993;100:681-4.
15. 2 control of T cell cytokine production is functionally related to the reduced lymphocyte proliferation in atopic dermatitis. J Allergy Clin Immunol 1996;97:85-94.
16. Ohman JD, Hanifin JM, Nickoloff BJ, et al. Overexpression of IL-10 in atopic dermatitis: contrasting cytokine patterns with delayed-type hypersensitivity reactions. J Immunol 1995;154:1956-63.
17. Cooper KD. Atopic dermatitis: recent trends in pathogenesis and therapy. J Invest Dermatol 1994;102:128-37.
18. Herz U, Bunikowski R, Renz H. Role of T cells in atopic dermatitis. Int Arch Allergy Immunol 1998;115:179-90.
19. Trede NS, Geha RS, Chatila T. Transcriptional activation of IL-1β and tumor necrosis factor-α genes by MHC Class II ligands. J Immunol 1991;146:310-5.
20. TokuraY, Yagi J, O'Malley M, et al. Superantigenic staphylococcal exotoxins induce T-cell proliferation in the presence of Langerhans cells or class II-bearing keratinocytes and stimulate keratinocytes to produce T-cell-activating cytokines. J Invest Dermatol 1994;102:31-8.
21. Pastore S, Fanales-Belasio E, Albanesi C, Chinni LM, Giannetti A, Girolomoni G. Granulocyte macrophage colony-stimulating factor is overproduced by keratinocytes in atopic dermatitis. J Clin Invest 1997;99:3009-17.
22. Schols D, Jones D, Roncarolo M-G. Unique cytokine production profile of anergic human T cells in SCID-hu mice after staphylococcal enterotoxin B administration. J Immunol 1995;154:3204-12.
23. Matz J, Williams J, Rosenwasser J, Borish LC. Granulocyte macrophage colony stimulating factor stimulates macrophages to respond to IgE via the low affinity IgE receptor (CD23). J Allergy Clin Immunol 1994;93:650-7.
24. Borish L, Mascali JJ, Rosenwasser LJ. IgE-dependent cytokine production by human peripheral blood mononuclear phagocytes. J Immunol 1991;146:63-7.
25. Mangan DF, Wahl SM. Differential regulation of human monocyte programmed cell death (apoptosis) by chemotactic factors and pro-inflammatory cytokines. J Immunol 1991;147:3408-12.